North America Is Dominating Huntington’s Disease Genetic Testing Industry

The global Huntington’s disease genetic testing market is projected to be worth USD 28.3 million by 2030, growing at a CAGR of 3.1%, according to P&S Intelligence. This growth can be credited to the reduced prices of genetic tests, high occurrence of Huntington's disease, steps taken by public and private establishments to increase awareness regarding HD, obtainability of several kinds of genetic tests, and the existence of a huge middle-aged populace.

Based on patient groups, the Huntington’s disease genetic testing industry was dominated by the adult category in recent years. The same is also projected to be dominant in the future as well, credited to the fact that HD is extremely dominant in adults, especially individuals in the age group of 30–50, who show the highest HD occurrence.

In the past few years, North America had the highest share in Huntington’s disease genetic testing market, credited to the existence of well-known market companies in the U.S. and the high occurrence of hereditary illnesses throughout the continent.

Additionally, the presence of a huge count of places where hereditary testing is conducted and high healthcare expenditure are the other major reasons accountable for the region’s supremacy in the worldwide industry.

The continent is further projected to advance at the highest pace in the coming few years, credited to the thriving elderly populace, growing research on hereditary syndromes, and increasing count of players providing complete genetic testing facilities in the U.S.

The huge middle-aged populace worldwide is projected to drive Huntington’s disease genetic testing industry. As per the World Bank, the populace aged 15–64 touched 5.0 billion in 2019 from 4.5 billion in 2010, globally.

Hence, the reduced prices of genetic tests, the high occurrence of Huntington's disease, steps taken by public and private establishments to increase awareness regarding HD, the obtainability of several kinds of genetic tests, and the existence of a huge middle-aged populace are the major factors propelling Huntington’s disease (HD) genetic testing market. 

Report this Page